Literature DB >> 3443064

Metabolism of [14C] felodipine, a new vasodilating drug, in healthy volunteers.

K J Hoffmann1, L Andersson.   

Abstract

After oral administration of [14C] felodipine (27.5mg) to 4 healthy volunteers, 6 main urinary metabolites were identified by gas chromatography-mass spectrometry. The compounds were isolated by solvent extraction at pH 2.2 and silylated prior to analysis. They were formed by dehydrogenation of felodipine followed by ester hydrolysis, hydroxylation of the alkyl groups and conjugation. These metabolites were excreted both as free acids and as conjugates accounting on average for 37% of the excreted amount (23% of the dose). A specific liquid chromatographic assay with radioactive detection was developed to determine the acidic metabolites in all collected samples. The urinary excretion rate declined biphasically for the mono-acids III and IV, whereas the excretion rates of metabolites VI, VII and VIII, formed via aliphatic hydroxylation, were better fitted to equations of first-order processes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3443064     DOI: 10.2165/00003495-198700343-00010

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  12 in total

1.  Pharmacokinetic parameter estimates from several least squares procedures: superiority of extended least squares.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1985-04

2.  Felodipine kinetics in healthy men.

Authors:  B Edgar; C G Regårdh; G Johnsson; L Johansson; P Lundborg; I Löfberg; O Rönn
Journal:  Clin Pharmacol Ther       Date:  1985-08       Impact factor: 6.875

3.  Bimodal column switching liquid chromatographic assay of six metabolites of [14C] felodipine in rat urine.

Authors:  L Weidolf
Journal:  J Chromatogr       Date:  1985-09-13

4.  Bioequivalence and metabolism of nitrendipine administered orally to healthy volunteers.

Authors:  J Kann; G J Krol; K D Raemsch; D E Burkholder; M J Levitt
Journal:  J Cardiovasc Pharmacol       Date:  1984       Impact factor: 3.105

5.  Identification of felodipine metabolites in rat urine.

Authors:  K J Hoffmann; L Weidolf
Journal:  Biomed Mass Spectrom       Date:  1985-08

6.  Vascular selectivity of felodipine.

Authors:  B Ljung
Journal:  Drugs       Date:  1985       Impact factor: 9.546

7.  In vivo pharmacokinetics of felodipine predicted from in vitro studies in rat, dog and man.

Authors:  C Bäärnhielm; H Dahlbäck; I Skånberg
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1986-08

8.  The metabolism and pharmacokinetics of nicardipine hydrochloride in man.

Authors:  D J Graham; R J Dow; D J Hall; O F Alexander; E J Mroszczak; D Freedman
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

9.  The metabolism of nicardipine hydrochloride in healthy male volunteers.

Authors:  W R Rush; O Alexander; D J Hall; L Cairncross; R J Dow; D J Graham
Journal:  Xenobiotica       Date:  1986-04       Impact factor: 1.908

10.  Biotransformation of felodipine in liver microsomes from rat, dog, and man.

Authors:  C Bäärnhielm; A Backman; K J Hoffmann; L Weidolf
Journal:  Drug Metab Dispos       Date:  1986 Sep-Oct       Impact factor: 3.922

View more
  6 in total

1.  A population study of the pharmacokinetics of felodipine.

Authors:  E Blychert; B Edgar; D Elmfeldt; T Hedner
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

2.  Pharmacokinetics and blood pressure effects of felodipine in elderly hypertensive patients. A comparison with young healthy subjects.

Authors:  S Landahl; B Edgar; M Gabrielsson; M Larsson; B Lernfelt; P Lundborg; C G Regårdh
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447

Review 3.  Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  E Saltiel; A G Ellrodt; J P Monk; M S Langley
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of felodipine. A summary.

Authors:  B Edgar; P Lundborg; C G Regårdh
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  Pharmacokinetics of felodipine in patients with impaired renal function.

Authors:  B Edgar; C G Regårdh; P O Attman; M Aurell; H Herlitz; G Johnsson
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

Review 6.  Felodipine clinical pharmacokinetics.

Authors:  P H Dunselman; B Edgar
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.